Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07508033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing

Study acronym: MSC-EXO vs PRF
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 2, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study evaluates two different treatments used to help the jawbone heal after a tooth is removed. When a tooth is extracted, the surrounding bone often shrinks, which can make it difficult to place dental implants later. Currently, doctors often use Platelet-Rich Fibrin (PRF), which is made from the patient's own blood, to help the area heal. This research compares PRF to a newer treatment using "exosomes" derived from stem cells. Exosomes are tiny particles that carry signals to tell the body to repair tissue and grow new bone. The goal of this study is to see if these exosomes work better than PRF at keeping the bone strong and thick after an extraction. Researchers will use specialized X-rays (CBCT) to measure the bone three months after the procedure to see which treatment provided better results.
Trial Details
NCT Number NCT07508033
Lead Sponsor Al Salam University
Conditions
(from sponsor)		 Alveolar Bone Loss, Tooth Extraction, Bone Regeneration
Related terms Alveolar Bone Loss
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov